Key Insights

Highlights

Research Leaders

15 sponsors active, led by IRCCS Azienda Ospedaliero-Universitaria di Bologna

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Recruiting1

Clinical Trials (1)

Research Network

Active Sponsors

  • IRCCS Azienda Ospedaliero-Universitaria di Bologna1
  • Asst Degli Spedali Civili Di Brescia1
  • Fondazione IRCCS Policlinico San Matteo, Pavia, Italy1
  • IRCCS Policlinico San Donato, Milano1
  • A.O.U. Città della Salute e della Scienza1

Related Conditions

  • Small Bowel Mucosal Atrophy Or Lesions1
  • Celiac Disease1

Activity Timeline